Granules Pharmaceuticals, Inc has entered into an agreement for product in-licensing.
Granules Pharmaceuticals, Inc., wholly owned subsidiary of Granules India Ltd has announced that it has entered into an agreement for product in-licensing.
Granules Pharmaceuticals, Inc., wholly owned subsidiary of Granules India Ltd has announced that it has entered into an agreement for product in-licensing.
Granules India Ltd is currently trading at Rs. 143, up by Rs. 3.25 or 2.33% from its previous closing of Rs. 139.75 on the BSE.
The scrip opened at Rs. 140.1 and has touched a high and low of Rs. 143.9 and Rs. 138.7 respectively. So far 1068535(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 3028.55 crore.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 164.45 on 01-Dec-2015 and a 52 week low of Rs. 75.55 on 12-Jun-2015. Last one week high and low of the scrip stood at Rs. 142.45 and Rs. 134.5 respectively.
The promoters holding in the company stood at 51.15 % while Institutions and Non-Institutions held 7.59 % and 41.26 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment